Skip to main content
Intermediate Technical IVT

tumor purity

The percentage of cancer cells relative to normal cells in a tissue sample. Essential metric for interpreting genomic test results and variant detection sensitivity.

Full Definition

Tumor purity refers to the proportion of malignant cells present in a tissue sample relative to contaminating normal cells, stromal cells, and immune infiltrates. This metric is crucial for precision oncology because low tumor purity can reduce the sensitivity of variant detection, particularly for mutations present at lower allelic frequencies. Most genomic profiling platforms require a minimum tumor purity threshold (typically 20-30%) for reliable results. Pathologists assess tumor purity through microscopic examination, and computational methods can estimate purity from sequencing data. Understanding tumor purity helps editors interpret why certain tests may fail or produce inconclusive results.

Usage

Usage note: Express as percentage; distinguish from tumor burden which refers to total amount of cancer in the body.

In Context

  • "The specimen demonstrated 70% tumor purity, meeting the threshold for comprehensive genomic profiling." — Pathology assessment
  • "Low tumor purity (15%) precluded reliable detection of low-frequency variants." — Laboratory limitation note

Also known as

tumor cellularity neoplastic cellularity

Contrasted with

stromal content normal cell contamination

Don't confuse with

tumor burden tumor load

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON